Evome Medical Technologies, Inc. Increase (Decrease) in Accounts Payable and Accrued Liabilities
Evome Medical Technologies, Inc. reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -CAD 972.45 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2024-04-16
- Evome Medical Technologies, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2023-12-31 was -3.18M CAD, a 1516.84% decline year-over-year.
- Evome Medical Technologies, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2023-09-30 was -179.39K CAD, a 119.06% decline year-over-year.
- Evome Medical Technologies, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2023-06-30 was 2.90M CAD, a 340.09% increase year-over-year.
- Evome Medical Technologies, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2023-03-31 was -513.09K CAD, a 198.46% decline year-over-year.
- Evome Medical Technologies, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was -972.45K CAD.
- Evome Medical Technologies, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was 1.52M CAD, a 72.59% increase from fiscal 2021.
- Evome Medical Technologies, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2021 was 878.61K CAD.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 10 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|---|
| 2023-12-31 | -3.18M CAD derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | -3.36M CAD derived: sum of 2 quarters · filed 2024-04-16 | -459.36K CAD derived: sum of 3 quarters · filed 2024-04-16 | -972.45K CAD 10-K · filed 2024-04-16 | |
| 2023-09-30 | -179.39K CAD derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | 2.72M CAD derived: sum of 2 quarters · filed 2023-11-14 | 2.21M CAD 10-Q · filed 2023-11-14 | ||
| 2023-06-30 | 2.90M CAD derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | 2.38M CAD 10-Q · filed 2023-08-14 | |||
| 2023-03-31 | -513.09K CAD 10-Q · filed 2023-05-15 | ||||
| 2022-12-31 | 1.88M CAD 10-K · filed 2024-04-16 | ||||
| 2022-11-30 | 224.30K CAD derived: 10-Q 9 month − 10-Q 6 month · filed 2023-01-17 | 1.39M CAD 10-Q · filed 2023-01-17 | |||
| 2022-09-30 | 941.25K CAD derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | 2.12M CAD 10-Q · filed 2023-11-14 | |||
| 2022-08-31 | 1.69M CAD derived: 10-Q 6 month − 10-Q 3 month · filed 2022-10-17 | 1.17M CAD 10-Q · filed 2022-10-17 | |||
| 2022-06-30 | 658.49K CAD derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | 1.18M CAD 10-Q · filed 2023-08-14 | |||
| 2022-05-31 | -523.94K CAD 10-Q · filed 2022-07-15 | ||||
| 2022-03-31 | 521.12K CAD 10-Q · filed 2023-05-15 | ||||
| 2022-02-28 | 643.64K CAD derived: 10-KT 12 month − 10-Q 9 month · filed 2023-04-03 | 936.89K CAD derived: sum of 2 quarters · filed 2023-04-03 | 1.02M CAD derived: sum of 3 quarters · filed 2023-04-03 | 1.52M CAD 10-KT · filed 2023-04-03 | |
| 2021-12-31 | 689.61K CAD 10-KT · filed 2023-04-03 | ||||
| 2021-11-30 | 293.25K CAD derived: 10-Q 9 month − 10-Q 6 month · filed 2023-01-17 | 374.63K CAD derived: sum of 2 quarters · filed 2023-01-17 | 872.73K CAD 10-Q · filed 2023-01-17 | 1.82M CAD derived: sum of 4 quarters · filed 2023-01-17 | |
| 2021-08-31 | 81.38K CAD derived: 10-Q 6 month − 10-Q 3 month · filed 2022-10-17 | 579.48K CAD 10-Q · filed 2022-10-17 | 1.53M CAD derived: sum of 3 quarters · filed 2022-10-17 | 1.56M CAD derived: sum of 4 quarters · filed 2022-10-17 | |
| 2021-05-31 | 498.10K CAD 10-Q · filed 2022-07-15 | 1.45M CAD derived: sum of 2 quarters · filed 2022-07-15 | 1.48M CAD derived: sum of 3 quarters · filed 2022-07-15 | 1.59M CAD derived: sum of 4 quarters · filed 2022-07-15 | |
| 2021-02-28 | 948.83K CAD derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-31 | 978.06K CAD derived: sum of 2 quarters · filed 2022-05-31 | 1.09M CAD derived: sum of 3 quarters · filed 2022-05-31 | 878.61K CAD 10-K · filed 2022-05-31 | |
| 2020-11-30 | 29.23K CAD derived: 10-Q 9 month − 10-Q 6 month · filed 2022-01-14 | 145.49K CAD derived: sum of 2 quarters · filed 2022-01-14 | -70.22K CAD 10-Q · filed 2022-01-14 | ||
| 2020-08-31 | 116.26K CAD derived: 10-Q 6 month − 10-Q/A 3 month · filed 2021-10-15 | -99.45K CAD 10-Q · filed 2021-10-15 | |||
| 2020-05-31 | -215.72K CAD 10-Q/A · filed 2021-08-02 |